Company profile
AnaCardio
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
- Location
- Solna, Stockholms Lan, Sweden, Europe
- Website
- anacardio.com
Latest known funding
Series B round
- Capital
- $70.8M
- Announced
- Sep 30, 2026